Key Insights

Highlights

Success Rate

75% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

20.0%

2 terminated out of 10 trials

Success Rate

75.0%

-11.5% vs benchmark

Late-Stage Pipeline

20%

2 trials in Phase 3/4

Results Transparency

83%

5 of 6 completed with results

Key Signals

5 with results75% success

Data Visualizations

Phase Distribution

8Total
Not Applicable (4)
P 1 (2)
P 4 (2)

Trial Status

Completed6
Terminated2
Withdrawn1
Unknown1

Trial Success Rate

75.0%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (10)

Research Network

Activity Timeline